BUZZ-U.S. STOCKS ON THE MOVE-Finish Line, Mechel, Mol Global, Aratana, ImmunoGen
(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for the Day Ahead newsletter, link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s) U.S. stocks were marginally higher on Friday, after the Federal Reserve's most recent policy statement sparked the best two-day run for the benchmark S&P 500 in three years.
The Dow Jones industrial average was up 0.21 percent at 17,815.91, the S&P 500 was up 0.37 percent at 2,068.82 and the Nasdaq Composite was up 0.22 percent at 4,758.882.
** IMMUNOGEN INC, $5.765, -46.87 pct
Roche said its new cancer drug, Kadcyla, failed to demonstrate an added benefit in breast cancer. Immunogen contributes technology to Kadcyla. ImmunoGen said it expects no impact on its 2015 forecast from the results.
** FINISH LINE INC, $23.29, -19.41 pct
The athletic shoes and apparel retailer posted a surprise third-quarter loss due to margin pressure and said full-year earnings would be flat, compared with its previous forecast of a high-single to low-double digit rise. The company also cut its same-store sales growth forecast and plans to "adjust" near-term capital spending plans.